Buscar resultados de ensayos clínicos
Carcinoma in Situ - 37 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ Condición: Ductal Carcinoma In Situ Fecha: 2016-08-30 Intervenciones: Procedure: Sentinel lymph node biopsy (SLNB) Intervention is defined as that the DCIS patient has underg |
Completed |
Nombre del estudio: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ Condición: Ductal Carcinoma in Situ Fecha: 2012-06-20 Intervenciones: Dietary Supplement: Black cohosh Remifemin 20 mg tablet orally twice per day x 4 weeks |
Completed |
Nombre del estudio: Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) Condición: Ductal Carcinoma In Situ Fecha: 2008-04-28 Intervenciones:
|
Completed |
Nombre del estudio: Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast Condición: Ductal Carcinoma In Situ Fecha: 2007-07-03 Intervenciones: Drug: Herceptin (Trastuzumab) 8 mg/kg IV Over 90 Minutes |
Terminated |
Nombre del estudio: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Condición: Ductal Carcinoma in Situ Fecha: 2009-03-06 Intervenciones: Drug: lapatinib 1500 mg lapatinib for 14-21 days Oth |
Terminated |
Nombre del estudio: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ Condición: Ductal Carcinoma in Situ Fecha: 2010-01-29 Intervenciones: Drug: Polyphenon E three 200mg capsules (600mg total dose of the study drug) with food (within one hour |
Completed |
Nombre del estudio: Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer Condición:
Fecha: 2012-11-12 Intervenciones: Drug: TMX-101 Other Name: Imiquimod |
Completed |
Nombre del estudio: Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) Condición:
Fecha: 2011-03-15 Intervenciones: Drug: Valrubicin, 800 mg Investigator will be responsible for regulating the use of concomitant medicati |
Completed |
Nombre del estudio: Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast Condición: Intraductal Carcinoma and Lobular Carcinoma in Situ Fecha: 2012-11-05 Intervenciones: Procedure: sentinel node biopsy and mastectomy sentinel node biopsy and mastectomy |
Recruiting |
Nombre del estudio: MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Condición: Ductal Breast Carcinoma In Situ Fecha: 2015-01-16 Intervenciones:
|